Mount Sinai Study Points to New Biological Mechanisms, Treatment Paradigm for Kidney Disease
March 3, 2014
Drug research and development should target cell-cell interactions that promote disease progression.
Mount Sinai And The Atlantic Host Working Summit On Big Data In New York City
October 29, 2013
Thought leaders from top medical centers, academia, and private industry discuss ways to harness the information revolution in health care, and use this vital data to improve the quality of patient care.
Mount Sinai Researchers Will Use $2.9 Million NIH Grant to Study Disease in Ethnically-Diverse Populations
September 13, 2013
Researchers will tap the Mount Sinai BioBank Program, BioMe™, which includes Electronic Medical Records on 29,000 patients.
Icahn School of Medicine at Mount Sinai Joins Drug-Induced Liver Injury Network
September 10, 2013
Mount Sinai has joined the Drug-Induced Liver Injury Network of the NIH to better undrestand drug-induced liver injury, which affects one million people each year.
Genetic Testing for Kidney Disease Among African-Americans With Hypertension to Become Part of Primary Care Offerings Through Mount Sinai and Partners
July 31, 2013
$3.7 million federal grant supports use of genomic information to refine personalized medicine.
Mount Sinai Study Identifies New Gene Variations Associated With Heart Rate
April 14, 2013
Findings pinpoint 14 genetic targets in humans that may provide insight for the treatment of cardiovascular disease
Personalized Medicine Takes A Giant Step Forward At The Mount Sinai Medical Center
April 5, 2013
New ‘CLIPMERGE’ program helps physicians identify gene-drug interactions to improve treatment decisions.
Mount Sinai Receives $3.4 Million Grant to Initiate First-Of-Its-Kind Study of Personalized Medicine in the Clinical Setting
August 18, 2011
Dr. Erwin Bottinger and his team are initiating the largest study to date using genetic information to help tailor individualized treatments in heart disease patients.
Data From Mount Sinai Biobank Provides Critical Insight Into Personalized Medicine
May 4, 2011
Mount Sinai researchers find that population labels may not be helpful in predicting disease risk or guiding how a patient will respond to certain medications, as previously thought.
Mount Sinai Charles R. Bronfman Institute for Personalized Medicine Biobank Enrolls 14,000
February 5, 2011
The Mount Sinai IPM Biobank, a unique institution that serves Mount Sinai’s many genomic research projects, has enrolled 14,000 Mount Sinai patients.
Personalized Medicine Arrives At Mount Sinai Medical Center
October 15, 2010
Clinical demonstration project offers genetic testing to help doctors predict if their patient will benefit from antiplatelet drug clopidrogel